Literature DB >> 14987992

Human herpesvirus 6 infection arrests cord blood mononuclear cells in G(2) phase of the cell cycle.

Leen De Bolle1, Sigrid Hatse, Erik Verbeken, Erik De Clercq, Lieve Naesens.   

Abstract

We here report that after infection with human herpesvirus 6A, human cord blood mononuclear cells accumulate in G(2)/M phase of the cell cycle. Experiments with foscarnet or ultraviolet (UV)-irradiated virus stocks pointed at an (immediate-)early, newly formed viral protein to be responsible for the arrest. At the molecular level, p53, cyclin B(1), cyclin A and tyrosine(15)-phosphorylated cdk1 accumulated after HHV-6A infection, indicating an arrest in G(2). However, no change was observed in the levels of downstream effectors of p53 in establishing a G(2) arrest, i.e. p21 and 14-3-3sigma. We thus conclude that the HHV-6A-induced G(2) arrest occurs independently of p53 accumulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14987992     DOI: 10.1016/S0014-5793(04)00035-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Virus manipulation of cell cycle.

Authors:  R Nascimento; H Costa; R M E Parkhouse
Journal:  Protoplasma       Date:  2011-10-11       Impact factor: 3.356

2.  Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion.

Authors:  Masaya Takemoto; Masato Koike; Yasuko Mori; Sayoko Yonemoto; Yumi Sasamoto; Kazuhiro Kondo; Yasuo Uchiyama; Koichi Yamanishi
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Human herpesvirus 6 (HHV-6) alters E2F1/Rb pathways and utilizes the E2F1 transcription factor to express viral genes.

Authors:  Eyal Sharon; Ludmila Volchek; Niza Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-12       Impact factor: 11.205

Review 4.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Human herpesvirus 6B induces cell cycle arrest concomitant with p53 phosphorylation and accumulation in T cells.

Authors:  Bodil Øster; Bettina Bundgaard; Per Höllsberg
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Myxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell cullin-1.

Authors:  J B Johnston; G Wang; J W Barrett; S H Nazarian; K Colwill; M Moran; G McFadden
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 7.  The development of new therapies for human herpesvirus 6.

Authors:  Mark N Prichard; Richard J Whitley
Journal:  Curr Opin Virol       Date:  2014-10-22       Impact factor: 7.090

8.  Human herpesvirus 6 suppresses T cell proliferation through induction of cell cycle arrest in infected cells in the G2/M phase.

Authors:  Lingyun Li; Bin Gu; Feng Zhou; Jing Chi; Fang Wang; Guangyong Peng; Fangyi Xie; Jian Qing; Dongju Feng; Shiqiang Lu; Kun Yao
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

9.  Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cells.

Authors:  Guy Mlechkovich; Niza Frenkel
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

10.  Direct Repeat 6 from human herpesvirus-6B encodes a nuclear protein that forms a complex with the viral DNA processivity factor p41.

Authors:  Mariane H Schleimann; Janni M L Møller; Emil Kofod-Olsen; Per Höllsberg
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.